IVI will complete the technology transfer by 2025 Oral Cholera Vaccine to be manufactured by Biological E. Limited for India and international markets SEOUL, Republic of Korea and HYDERABAD, India — The International Vaccine Institute (IVI), an international organization with a mission to discover,
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy Venus Remedies is among the largest Indian exporters of these drugs Ukraine is among the largest countries in Europe and its pharmaceutical market has been witnessing
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF This achievement is an endorsement of Venus Remedies' commitment to delivering top-quality pharmaceutical products worldwide Venus Remedies Limited, a leading global pharmaceutical company, has recently secured
The disbursement will bolster the company’s manufacturing capabilities and foster product diversification, including complex generics The grant emphasises the company’s commitment to driving innovation, entitles it to incentives for incremental sales of eligible pharmaceutical products Venus Remedies Ltd, one of India’s leading manufacturers of generic
Quote for International Women’s Day from Priyanka Chigurupati, Executive Director, Granules India Ltd. "As we commemorate International Women's Day, it's important to recognize the strides we have made towards gender equality yet acknowledge that we have miles to go. In the pharmaceutical industry, we are at
Emerges as the ONLY Healthcare Marketing Platform that ensures Real-Time Programmatic message delivery across POC platforms triggered by clinical data, AT SCALE The largest global marketing platform to reach 5 M+ HCPs across 25+ countries through 4000+ marketing campaigns Doceree, the leading global healthcare
Indian pharma companies are incorporating AI algorithms into their R&D operations, clinical trials and streamlining processes Firms deploying GenAI are seeing reduction in early-stage drug development costs, and improvement in operational efficiencies EY Parthenon (EY-P), the leading strategy consulting firm, in partnership with BioAsia,
Biological E. Limited (BE) to Manufacture Up to 50 Million Doses of QDENGA Per Year, Accelerating Takeda’s Ability to Deliver 100 Million Doses Per Year by 2030 At the Latest Addresses the Specific Need to Offer Multi-Dose Vials for National Immunization Programs to
Aparna Pharmaceuticals Private Limited, a leader in manufacturing Active Pharmaceutical Ingredients (APIs) and Advanced Drug Intermediates, is pleased to announce that its manufacturing facility, Aparna Organics Limited, located in Pydibhimavaram, Srikakulalam, Andhra Pradesh, India has received VAI classification from the United States Food and Drug
This GMP certification for the company’s production facilities has added to its portfolio of international approvals from 25 regulators The recognition demonstrates Venus Remedies’ persistence in adhering to stringent manufacturing standards and providing greater access to life-saving drugs in the African continent Venus Remedies, a
